Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Skuli

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Biorxiv : the Preprint Server for Biology|May 7, 2024
A mitochondrial surveillance mechanism activated by <i>SRSF2</i> mutations in hematologic malignanciesXiaolei Liu, Sudhish A Devadiga, Robert F Stanley, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2013
miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastomaLijoy K Mathew, Nicolas Skuli, Vera Mucaj, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Nuclear speckles regulate HIF-2α programs and correlate with patient survival in kidney cancerKatherine A Alexander, Ruofan Yu, Nicolas Skuli, et al.
The Journal of Clinical Investigation|May 7, 2024
A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignanciesXiaolei Liu, Sudhish A Devadiga, Robert F Stanley, et al.
Cancer Research|February 28, 2024
Bile Acid Metabolism Mediates Cholesterol Homeostasis and Promotes Tumorigenesis in Clear Cell Renal Cell CarcinomaRomain Riscal, Sarah M Gardner, Nathan J Coffey, et al.
Scientific Reports|November 4, 2017
HIF-1α- Targeting Acriflavine Provides Long Term Survival and Radiological Tumor Response in Brain Cancer TherapyAntonella Mangraviti, Tula Raghavan, Francesco Volpin, et al.
Nature Cell Biology|January 2, 2025
Nuclear speckles regulate functional programs in cancerKatherine A Alexander, Ruofan Yu, Nicolas Skuli, et al.
Nature Immunology|May 7, 2013
Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathwaysJiyeon S Kim, Tammarah Sklarz, Lauren B Banks, et al.
Molecular Cancer Therapeutics|July 2, 2020
Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal CarcinomaSakibul Huq, Joshua Casaos, Riccardo Serra, et al.
Cancer Discovery|July 10, 2021
Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell CarcinomaRomain Riscal, Caroline J Bull, Clementina Mesaros, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|May 7, 2024
A mitochondrial surveillance mechanism activated by <i>SRSF2</i> mutations in hematologic malignanciesXiaolei Liu, Sudhish A Devadiga, Robert F Stanley, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2013
miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastomaLijoy K Mathew, Nicolas Skuli, Vera Mucaj, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Nuclear speckles regulate HIF-2α programs and correlate with patient survival in kidney cancerKatherine A Alexander, Ruofan Yu, Nicolas Skuli, et al.
The Journal of Clinical Investigation|May 7, 2024
A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignanciesXiaolei Liu, Sudhish A Devadiga, Robert F Stanley, et al.
Cancer Research|February 28, 2024
Bile Acid Metabolism Mediates Cholesterol Homeostasis and Promotes Tumorigenesis in Clear Cell Renal Cell CarcinomaRomain Riscal, Sarah M Gardner, Nathan J Coffey, et al.
Scientific Reports|November 4, 2017
HIF-1α- Targeting Acriflavine Provides Long Term Survival and Radiological Tumor Response in Brain Cancer TherapyAntonella Mangraviti, Tula Raghavan, Francesco Volpin, et al.
Nature Cell Biology|January 2, 2025
Nuclear speckles regulate functional programs in cancerKatherine A Alexander, Ruofan Yu, Nicolas Skuli, et al.
Nature Immunology|May 7, 2013
Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathwaysJiyeon S Kim, Tammarah Sklarz, Lauren B Banks, et al.
Molecular Cancer Therapeutics|July 2, 2020
Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal CarcinomaSakibul Huq, Joshua Casaos, Riccardo Serra, et al.
Cancer Discovery|July 10, 2021
Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell CarcinomaRomain Riscal, Caroline J Bull, Clementina Mesaros, et al.
Pageof 7